Showing 11 - 20 of 523
Persistent link: https://www.econbiz.de/10011568193
Persistent link: https://www.econbiz.de/10003751828
Persistent link: https://www.econbiz.de/10003974216
Persistent link: https://www.econbiz.de/10011290938
We construct a model of innovation incorporating R&D externalities, R&D participation, financial market imperfections, and application and allocation of R&D subsidies, estimate it using Finnish R&D project level data and conduct a welfare analysis. The intensive, not the extensive R&D margin is...
Persistent link: https://www.econbiz.de/10012815311
This paper studies the welfare effects of R&D subsidies. We develop a model of continuous optimal treatment with outcome heterogeneity where the treatment outcome depends on applicant investment. The model takes into account heterogeneous application costs and identifies the treatment effect on...
Persistent link: https://www.econbiz.de/10012148029
We extend the theoretical basis of the empirical literature on the effects of R&D subsidies by providing an estimable model of strategic interaction among subsidy applicants, and public and private sector R&D financiers. Our model incorporates fixed R&D costs and a cost of external finance. We...
Persistent link: https://www.econbiz.de/10012148173
We conduct a welfare analysis of R&D subsidies and tax credits using a model of innovation policy in corporating externalities, limited R&D participation and finanial market imperfetions. We estimate the model using R&D projet level data from Finland. The optimal R&D tax credit rate (0.24) is...
Persistent link: https://www.econbiz.de/10012148332
We extend the theoretical basis of the empirical literature on the effects of R&D subsidies by providing an estimable model of strategic interaction among subsidy applicants, and public and private sector R&D financiers. Our model incorporates fixed R&D costs and a cost of external finance. We...
Persistent link: https://www.econbiz.de/10013086771
This paper studies the welfare effects of Ramp;D subsidies. We develop a model of continuous optimal treatment with outcome heterogeneity where the treatment outcome depends on applicant investment. The model takes into account heterogeneous application costs and identifies the treatment effect...
Persistent link: https://www.econbiz.de/10012725099